Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FENC | IPHA | CDTX | ||
| Company | Fennec Pharmaceuticals Inc | Innate Pharma S.A. ADR | Cidara Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.73 | 2.08 | 22.12 | ||
| High | 6.00 | 2.10 | 24.00 | ||
| Low | 5.73 | 2.03 | 21.20 | ||
| Last | 5.99 | 2.05 | 23.22 | ||
| Change | +0.15 | -0.11 | +0.71 | ||
| % Change | +2.57% | -5.09% | +3.15% | ||
| Volume | 172,900 | 48,400 | 148,300 | ||
| 20-Day Average Volume | 165,400 | 1,473,745 | 75,075 | ||
| Previous Close | 5.84 | 2.16 | 22.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.98 | 1.79 | 21.13 | ||
| 20-Day Raw Stochastic | 70.14% | 30.47% | 77.13% | ||
| 20-Day Relative Strength | 57.54% | 52.80% | 64.03% | ||
| Weighted Alpha | -41.90 | -52.69 | +57.87 | ||
| Today's Opinion | 8% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 8% Sell | 24% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.99% since 12/13/24 | -32.12% since 12/13/24 | +1.49% since 12/13/24 | ||
| Low | 5.51 on 12/19/24 | 2.03 on 12/20/24 | 19.24 on 12/18/24 | ||
| High | 6.17 on 12/17/24 | 2.67 on 12/16/24 | 24.99 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +29.09% since 11/20/24 | +21.63% since 11/20/24 | +53.57% since 11/20/24 | ||
| Low | 4.60 on 11/21/24 | 1.41 on 12/04/24 | 17.17 on 11/21/24 | ||
| High | 6.55 on 11/27/24 | 3.51 on 12/13/24 | 24.99 on 12/17/24 | ||
| 3-Month | |||||
| %Chg | +14.31% since 09/20/24 | -8.89% since 09/20/24 | +106.03% since 09/20/24 | ||
| Low | 3.96 on 11/18/24 | 1.29 on 11/18/24 | 10.14 on 10/15/24 | ||
| High | 6.55 on 11/27/24 | 3.51 on 12/13/24 | 24.99 on 12/17/24 | ||
| 6-Month | |||||
| %Chg | -8.41% since 06/20/24 | -4.21% since 06/20/24 | +98.46% since 06/20/24 | ||
| Low | 3.96 on 11/18/24 | 1.29 on 11/18/24 | 10.14 on 10/15/24 | ||
| High | 6.91 on 07/17/24 | 3.51 on 12/13/24 | 24.99 on 12/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 164,545 | 165,982 | 163,622 | ||
| Shares Outstanding, K | 27,470 | 80,967 | 7,047 | ||
| Annual Sales | 21,250,000 | 66,710,000 | 63,910,000 | ||
| Annual Net Income | -16,050,000 | -8,190,000 | -22,930,000 | ||
| Last Quarter Sales | 6,970,000 | N/A | 300,000 | ||
| Last Quarter Net Income | -5,740,000 | N/A | -91,210,000 | ||
| 60-Month Beta | 0.35 | 0.34 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/07/24 | N/A | -2.38 on 11/07/24 | ||
| Latest Earnings Date | 11/07/24 | 11/13/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||